Clinical Trial Update: Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting the completion of Phase 2 and Phase 3 studies evaluating dexmedetomidine to lessen ICU agitation in patients with delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Austin Health | Conditions: Delirium | Phase 2, Phase 3 | Status: COMPLETED